WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. today announced second-quarter 2007 results that reflected an increase in earnings per share of 12% fueled by strong performance across a broad range of the Company’s products. Worldwide sales were $6.1 billion for the quarter, an increase of 6% from the second quarter of 2006. Net income for the second quarter of 2007 was $1,676.4 million, compared to $1,499.3 million in the second quarter of 2006. Net income and EPS for the second quarter of 2007 include the impact of reserving an additional $210 million solely for future VIOXX legal defense costs. Net income and EPS for the second quarter of 2006 include the impact of a $296 million acquired research charge related to the GlycoFi, Inc. acquisition. Net income was $3,380.7 million and worldwide sales were $11.9 billion for the first six months of 2007. Total sales increased 6% for the same period. A reconciliation of EPS as reported in accordance with generally accepted accounting principles (GAAP) to EPS, adjusted for certain significant items, is provided in the table below.
